FDA Smacks Pravachol for Misleading Ads

Direct-to-consumer drug advertising has tripled to $2.8 billion worth a year since the FDA loosened restrictions in 1997. Manufacturers spend almost twice that amount on sales visits to doctors to promote their products, and another $2 billion on "educational" events. If this story interests you, please review the Lancet article I posted earlier this year on how drug ads in medical journals are also highly deceptive. Associated Press August 9, 2003

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports